Previous Close | 6.77 |
1-Year Change | 41.04% |
6-Months Change | -37.26% |
3-Months Change | -16.11% |
Moving Avg (50d) | 8.5622 |
Moving Avg (200d) | 8.8166 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 1.83B |
Beta (3-Years) | 1.86 |
Revenue Growth (ttm) | -92.22% |
Net Profit Margin (ttm) | -19270.71% |
Return On Assets (ttm) | -85.23% |
EPS (ttm) | -0.63 |
PE Ratio (ttm) | -10.75 |
Dividend Yield | % |
Asset Description: | Inovio Pharmaceuticals, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Neutral |
Forecast Date: | 2024-07-30 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
6.905 | 7.108 | 7.244 | 7.447 | 7.785 | 8.124 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.